{
    "nctId": "NCT04136912",
    "briefTitle": "3-D Super Resolution Ultrasound Microvascular Imaging",
    "officialTitle": "High Frame Rate 3-D Super Resolution Ultrasound Microvascular Imaging",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Thyroid Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 45,
    "primaryOutcomeMeasure": "Sensitivity of Acoustic Angiography; Breast Imaging (percent of positive scans)",
    "eligibilityCriteria": "Healthy Volunteers\n\nInclusion Criteria\n\n* Able to provide informed consent\n* Negative urine pregnancy test in women of child-bearing potential\n\nExclusion Criteria\n\n* Institutionalized subject (prisoner or nursing home patient)\n* Critically ill or medically unstable and whose critical course during the observation period would be unpredictable (e.g., chronic obstructive pulmonary disease (COPD)\n* Known hypersensitivity to perflutren lipid (Definity\u00ae)\n* Active cardiac disease including any of the following:\n\n  * Severe congestive heart failure\n  * Unstable angina.\n  * Severe arrhythmia\n  * Myocardial infarction within 14 days prior to the date of proposed Definity\u00ae administration.\n  * Pulmonary hypertension\n  * Cardiac shunts\n\nBreast Imaging Patients\n\nInclusion Criteria\n\n* Women\n* Patient had a diagnostic breast ultrasound study performed at UNC\n* Scheduled for a core needle or surgical breast biopsy of at least one breast lesion that is 2 cm or less in size and 3 cm in depth from the skin surface\n* Able to provide informed consent\n* Negative urine pregnancy test in women of child-bearing potential\n* BIRADS score of 4 or 5.\n\nExclusion Criteria\n\n* Male\n* Institutionalized subject (prisoner or nursing home patient)\n* Critically ill or medically unstable and whose critical course during the observation period would be unpredictable (e.g., chronic obstructive pulmonary disease (COPD)\n* Sonographically visible breast lesion larger than 2cm or greater than 3cm in depth from the skin surface\n* Known hypersensitivity to perflutren lipid (Definity\u00ae)\n* Active cardiac disease including any of the following:\n\n  * Severe congestive heart failure\n  * Unstable angina.\n  * Severe arrhythmia\n  * Myocardial infarction within 14 days prior to the date of proposed Definity\u00ae administration.\n  * Pulmonary hypertension\n  * Cardiac shunts\n\nThyroid Imaging Patients Inclusion Criteria\n\n* Patient had a diagnostic thyroid ultrasound study performed at UNC\n* TIRADS risk score of 4c or 5\n* Scheduled for a core needle or surgical thyroid biopsy, fine needle aspiration, or thyroidectomy of at least one sonographically visible thyroid lesion that is 3 cm in depth from the skin surface\n* Able to provide informed consent\n* Negative urine pregnancy test in women of child-bearing potential\n\nExclusion Criteria\n\n* Institutionalized subject (prisoner or nursing home patient)\n* Critically ill or medically unstable and whose critical course during the observation period would be unpredictable (e.g., chronic obstructive pulmonary disease (COPD)\n* Known hypersensitivity to perflutren lipid (Definity\u00ae)\n* Active cardiac disease including any of the following:\n\n  * Severe congestive heart failure\n  * Unstable angina.\n  * Severe arrhythmia\n  * Myocardial infarction within 14 days prior to the date of proposed Definity\u00ae administration.\n  * Pulmonary hypertension\n  * Cardiac shunts",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}